Citations (34)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Douglas G McNeel, Yu-Hui Chen, James L Gulley, Alexander J Dwyer, Ravi A Madan, Michael A Carducci & Robert S DiPaola. (2015) Randomized phase II trial of docetaxel with or without PSA-TRICOM vaccine in patients with castrate-resistant metastatic prostate cancer: A trial of the ECOG-ACRIN cancer research group (E1809). Human Vaccines & Immunotherapeutics 11:10, pages 2469-2474.
Read now
Read now
Erica Jackson & Hatem Soliman. (2012) Realizing the promise of breast cancer vaccines. Vaccine: Development and Therapy 2, pages 35-41.
Read now
Read now
James L Gulley, Ravi A Madan, Kwong-Yok Tsang, Philip M Arlen, Kevin Camphausen, Mahsa Mohebtash, Mitchell Kamrava, Jeffrey Schlom & Deborah Citrin. (2011) A pilot safety trial investigating a vector-based vaccine targeting carcinoembryonic antigen in combination with radiotherapy in patients with gastrointestinal malignancies metastatic to the liver. Expert Opinion on Biological Therapy 11:11, pages 1409-1418.
Read now
Read now
Ravi A Madan, Jeanny B Aragon-Ching, James L Gulley & William L Dahut. (2011) From clinical trials to clinical practice: therapeutic cancer vaccines for the treatment of prostate cancer. Expert Review of Vaccines 10:6, pages 743-753.
Read now
Read now
Ravi A Madan & James L Gulley. (2011) Sipuleucel-T: harbinger of a new age of therapeutics for prostate cancer. Expert Review of Vaccines 10:2, pages 141-150.
Read now
Read now
Mudita Pincha, Bala Sai Sundarasetty & Renata Stripecke. (2010) Lentiviral vectors for immunization: an inflammatory field. Expert Review of Vaccines 9:3, pages 309-321.
Read now
Read now
Ravi A Madan, Mahsa Mohebtash, Jeffrey Schlom & James L Gulley. (2010) Therapeutic vaccines in metastatic castration-resistant prostate cancer: principles in clinical trial design. Expert Opinion on Biological Therapy 10:1, pages 19-28.
Read now
Read now
Ravi A Madan, Philip M Arlen, Mahsa Mohebtash, James W Hodge & James L Gulley. (2009) Prostvac-VF: a vector-based vaccine targeting PSA in prostate cancer. Expert Opinion on Investigational Drugs 18:7, pages 1001-1011.
Read now
Read now
Ravi A Madan, Philip M Arlen & James L Gulley. (2007) PANVAC™-VF: poxviral-based vaccine therapy targeting CEA and MUC1 in carcinoma. Expert Opinion on Biological Therapy 7:4, pages 543-554.
Read now
Read now
Miriam E Mossoba & Jeffrey A Medin. (2006) Cancer immunotherapy using virally transduced dendritic cells: animal studies and human clinical trials. Expert Review of Vaccines 5:5, pages 717-732.
Read now
Read now
Christian A Petrulio & Howard L Kaufman. (2006) Development of the PANVAC™-VF vaccine for pancreatic cancer. Expert Review of Vaccines 5:1, pages 9-19.
Read now
Read now
Articles from other publishers (23)
Chiara Focaccetti, Monica Benvenuto, Sara Ciuffa, Sara Fazi, Manuel Scimeca, Alessandra Nardi, Martino Tony Miele, Andrea Battisti, Elena Bonanno, Andrea Modesti, Laura Masuelli & Roberto Bei. (2020) Curcumin Enhances the Antitumoral Effect Induced by the Recombinant Vaccinia Neu Vaccine (rV-neuT) in Mice with Transplanted Salivary Gland Carcinoma Cells. Nutrients 12:5, pages 1417.
Crossref
Crossref
Shivani Handa, Bandhul Hans, Shokhi Goel, Hafis O. Bashorun, Zach Dovey & Ashutosh Tewari. (2020) Immunotherapy in prostate cancer: current state and future perspectives. Therapeutic Advances in Urology 12, pages 175628722095140.
Crossref
Crossref
Juan J. Rojas, Padma Sampath, Braulio Bonilla, Alexandra Ashley, Weizhou Hou, Daniel Byrd & Steve H. Thorne. (2016) Manipulating TLR Signaling Increases the Anti-tumor T Cell Response Induced by Viral Cancer Therapies. Cell Reports 15:2, pages 264-273.
Crossref
Crossref
Laura Masuelli, Massimo Fantini, Monica Benvenuto, Pamela Sacchetti, Maria Gabriella Giganti, Ilaria Tresoldi, Paolo Lido, Florigio Lista, Federica Cavallo, Patrizia Nanni, Jeffrey Schlom, Andrea Modesti & Roberto Bei. (2014) Intratumoral delivery of recombinant vaccinia virus encoding for ErbB2/Neu inhibits the growth of salivary gland carcinoma cells. Journal of Translational Medicine 12:1.
Crossref
Crossref
Ravi A. Madan, Theresa A. Ferrara & James L. Gulley. 2014. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics. Handbook of Anticancer Pharmacokinetics and Pharmacodynamics
553
568
.
R B Kennedy, A L Oberg, I G Ovsyannikova, I H Haralambieva, D Grill & G A Poland. (2013) Transcriptomic profiles of high and low antibody responders to smallpox vaccine. Genes & Immunity 14:5, pages 277-285.
Crossref
Crossref
Ravi A. Madan, James L. Gulley & Philip W. Kantoff. (2013) Demystifying Immunotherapy in Prostate Cancer. The Cancer Journal 19:1, pages 50-58.
Crossref
Crossref
Felicia Roscoe, Ren-Huan Xu & Luis J. Sigal. (2012)
Characterization of Ectromelia Virus Deficient in
EVM036
, the Homolog of Vaccinia virus
F13L
, and Its Application for Rapid Generation of Recombinant Viruses
. Journal of Virology 86:24, pages 13501-13507.
Crossref
Crossref
Marijo Bilusic & Ravi A. Madan. (2012) Therapeutic Cancer Vaccines. American Journal of Therapeutics 19:6, pages e172-e181.
Crossref
Crossref
Mahsa Mohebtash, Kwong-Yok Tsang, Ravi A. Madan, Ngar-Yee Huen, Diane J. Poole, Caroline Jochems, Jacquin Jones, Theresa Ferrara, Christopher R. Heery, Philip M. Arlen, Seth M. Steinberg, Mary Pazdur, Myrna Rauckhorst, Elizabeth C. Jones, William L. Dahut, Jeffrey Schlom & James L. Gulley. (2011) A Pilot Study of MUC-1/CEA/TRICOM Poxviral-Based Vaccine in Patients with Metastatic Breast and Ovarian Cancer. Clinical Cancer Research 17:22, pages 7164-7173.
Crossref
Crossref
Ravi A. Madan & James L. Gulley. (2010) The Current and Emerging Role of Immunotherapy in Prostate Cancer. Clinical Genitourinary Cancer 8:1, pages 10-16.
Crossref
Crossref
Laura Masuelli, Laura Marzocchella, Chiara Focaccetti, Florigio Lista, Alessandra Nardi, Antonio Scardino, Maurizio Mattei, Mario Turriziani, Mauro Modesti, Guido Forni, Jeffrey Schlom, Andrea Modesti & Roberto Bei. (2010) Local delivery of recombinant vaccinia virus encoding for neu counteracts growth of mammary tumors more efficiently than systemic delivery in neu transgenic mice. Cancer Immunology, Immunotherapy 59:8, pages 1247-1258.
Crossref
Crossref
Ravi A. Madan, James L. Gulley, Jackie Celestin, Philip M. Arlen & Jeffrey Schlom. 2010. Drug Management of Prostate Cancer. Drug Management of Prostate Cancer
305
319
.
David H. Kirn & Steve H. Thorne. (2009) Targeted and armed oncolytic poxviruses: a novel multi-mechanistic therapeutic class for cancer. Nature Reviews Cancer 9:1, pages 64-71.
Crossref
Crossref
Ravi A. Madan, James L. Gulley, Jeffrey Schlom, Seth M. Steinberg, David J. Liewehr, William L. Dahut & Philip M. Arlen. (2008) Analysis of Overall Survival in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Vaccine, Nilutamide, and Combination Therapy. Clinical Cancer Research 14:14, pages 4526-4531.
Crossref
Crossref
Anna Ohradanova, Daniela Vullo, Juraj Kopacek, Claudia Temperini, Tatiana Betakova, Silvia Pastorekova, Jaromir Pastorek & Claudiu T. Supuran. (2007) Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus. Biochemical Journal 407:1, pages 61-67.
Crossref
Crossref
S Yang, Z S Guo, M E O'Malley, X Yin, H J Zeh & D L Bartlett. (2007) A new recombinant vaccinia with targeted deletion of three viral genes: its safety and efficacy as an oncolytic virus. Gene Therapy 14:8, pages 638-647.
Crossref
Crossref
Kevin P. NishimotoAmanda K. LaustKehui WangKurt I. KamrudBolyn HubbyJonathan F. SmithEdward L. Nelson. (2007) Restricted and Selective Tropism of a Venezuelan Equine Encephalitis Virus-Derived Replicon Vector for Human Dendritic Cells. Viral Immunology 20:1, pages 88-104.
Crossref
Crossref
E. R. Tulman, G. Delhon, C. L. Afonso, Z. Lu, L. Zsak, N. T. Sandybaev, U. Z. Kerembekova, V. L. Zaitsev, G. F. Kutish & D. L. Rock. (2006) Genome of Horsepox Virus. Journal of Virology 80:18, pages 9244-9258.
Crossref
Crossref
Z. Sheng Guo, Arpana Naik, Mark E. O'Malley, Petar Popovic, Richard Demarco, Yun Hu, Xiaoyu Yin, Shuting Yang, Herbert J. Zeh, Bernard Moss, Michael T. Lotze & David L. Bartlett. (2005)
The Enhanced Tumor Selectivity of an Oncolytic Vaccinia Lacking the Host Range and Antiapoptosis Genes
SPI-1
and
SPI-2
. Cancer Research 65:21, pages 9991-9998.
Crossref
Crossref
C. M. Britten & U. Sahin. (2005) Impfstrategien zur Prävention oder Therapie von TumorenVaccination strategies for the prevention and therapy of cancer. Der Onkologe 11:5, pages 502-513.
Crossref
Crossref
Grant McFadden. (2005) Poxvirus tropism. Nature Reviews Microbiology 3:3, pages 201-213.
Crossref
Crossref
J.B. Johnston, Steven H. Nazarian, Renato Natale & Grant McFadden. (2005) Myxoma virus infection of primary human fibroblasts varies with cellular age and is regulated by host interferon responses. Virology 332:1, pages 235-248.
Crossref
Crossref